Downstream	O
activation	O
of	O
a	O
TATA-less	B-DNA
promoter	I-DNA
by	O
Oct-2	B-protein
,	O
Bob1	O
,	O
and	O
NF-kappaB	B-protein
directs	O
expression	O
of	O
the	O
homing	B-protein
receptor	I-protein
BLR1	I-protein
to	O
mature	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

The	O
chemokine	B-protein
receptor	I-protein
,	O
BLR1	B-protein
,	O
is	O
a	O
major	O
regulator	O
of	O
the	O
microenvironmental	O
homing	O
of	O
B	B-cell_type
cells	I-cell_type
in	O
lymphoid	O
organs	O
.	O

In	O
vitro	O
studies	O
identify	O
three	O
essential	O
elements	O
of	O
the	O
TATA-less	B-DNA
blr1	I-DNA
core	I-DNA
promoter	I-DNA
that	O
confer	O
cell	O
type-	O
and	O
differentiation-specific	O
expression	O
in	O
the	O
B	B-cell_type
cells	I-cell_type
of	O
both	O
humans	O
and	O
mice	O
,	O
a	O
functional	B-DNA
promoter	I-DNA
region	I-DNA
(	O
-36	O
with	O
respect	O
to	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
)	O
,	O
a	O
NF-kappaB	B-DNA
motif	I-DNA
(	O
+44	O
)	O
,	O
and	O
a	O
noncanonical	B-DNA
octamer	I-DNA
motif	I-DNA
(	O
+157	O
)	O
.	O

The	O
importance	O
of	O
these	O
sites	O
was	O
confirmed	O
by	O
in	O
vivo	O
studies	O
in	O
gene-targeted	O
mice	O
deficient	O
of	O
either	O
Oct-2	B-protein
,	O
Bob1	B-protein
,	O
or	O
both	O
NF-kappaB	B-protein
subunits	O
p50	O
and	O
p52	O
.	O

In	O
all	O
of	O
these	O
animals	O
,	O
the	O
expression	O
of	O
BLR1	B-protein
was	O
reduced	O
or	O
absent	O
.	O

In	O
mice	O
deficient	O
only	O
of	O
p52/NF-kappaB	B-protein
,	O
BLR1	B-protein
expression	O
was	O
unaffected	O
.	O

Thus	O
our	O
data	O
demonstrate	O
that	O
BLR1	B-protein
is	O
a	O
target	O
gene	O
for	O
Oct-2	B-protein
,	O
Bob1	B-protein
,	O
and	O
members	O
of	O
the	O
NF-kappaB/Rel	B-protein
family	I-protein
and	O
provides	O
a	O
link	O
to	O
the	O
impaired	O
B	O
cell	O
functions	O
in	O
mice	O
deficient	O
for	O
these	O
factors	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

273	NULL
,	NULL
No	NULL
.	NULL

44	NULL
,	NULL
Issue	NULL
of	NULL
October	NULL
30	NULL
,	NULL
pp	NULL
.	NULL

28831-28836	NULL
,	NULL
1998	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Downstream	NULL
Activation	NULL
of	NULL
a	NULL
TATA-less	NULL
Promoter	NULL
by	NULL
Oct-2	NULL
,	NULL
Bob1	NULL
,	NULL
and	NULL
NF-B	NULL
Directs	NULL
Expression	NULL
of	NULL
the	NULL
Homing	NULL
Receptor	NULL
BLR1	NULL
to	NULL
Mature	NULL
B	NULL
Cells*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
July	NULL
22	NULL
,	NULL
1998	NULL
)	NULL
Ingrid	NULL
Veniamin	NULL
Pevzner	NULL
}	NULL
1**	NULL
,	NULL
Edelgard	NULL
Kaiser§	NULL
,	NULL
Giinter	NULL
Bernhardt	NULL
}	NULL
,	NULL
Estefania	NULL
Ulrich	NULL
Siebenlist	NULL
}	NULL
#	NULL
$	NULL
,	NULL
Reinhold	NULL
Forster	NULL
}	NULL
,	NULL
and	NULL
Martin	NULL
Lipp	NULL
$	NULL
$	NULL
§	NULL
§§	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Tumorgenetics	NULL
and	NULL
Immunogenetics	NULL
,	NULL
Max	NULL
Delbriick	NULL
Center	NULL
for	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Robert-Rossle-Strasse	NULL
10	NULL
,	NULL
D-13122	NULL
,	NULL
Berlin-Buch	NULL
,	NULL
Germany	NULL
,	NULL
the	NULL
§Institut	NULL
filr	NULL
Biochemie	NULL
,	NULL
Ludwig	NULL
Maximilians	NULL
Universitit	NULL
Miinchen	NULL
,	NULL
Feodor-Lynen-Strasse	NULL
25	NULL
,	NULL
D-81377	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
,	NULL
and	NULL
the	NULL
{	NULL
{	NULL
Laboratory	NULL
of	NULL
Immunoregulation	NULL
,	NULL
NICHD	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
The	NULL
chemokine	NULL
receptor	NULL
,	NULL
BLR1	NULL
,	NULL
is	NULL
a	NULL
major	NULL
regulator	NULL
of	NULL
the	NULL
microenvironmental	NULL
homing	NULL
of	NULL
B	NULL
cells	NULL
in	NULL
lymphoid	NULL
organs	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
identify	NULL
three	NULL
essential	NULL
elements	NULL
of	NULL
the	NULL
TATA-less	NULL
birl	NULL
core	NULL
promoter	NULL
that	NULL
confer	NULL
cell	NULL
type-	NULL
and	NULL
differentiation-specific	NULL
expression	NULL
in	NULL
the	NULL
B	NULL
cells	NULL
of	NULL
both	NULL
humans	NULL
and	NULL
mice	NULL
,	NULL
a	NULL
functional	NULL
promoter	NULL
region	NULL
(	NULL
-36	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
,	NULL
a	NULL
NF-B	NULL
motif	NULL
(	NULL
+44	NULL
)	NULL
,	NULL
and	NULL
a	NULL
noncanonical	NULL
octamer	NULL
motif	NULL
(	NULL
+157	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
these	NULL
sites	NULL
was	NULL
confirmed	NULL
by	NULL
in	NULL
vivo	NULL
studies	NULL
in	NULL
gene-targeted	NULL
mice	NULL
deficient	NULL
of	NULL
either	NULL
Oct-2	NULL
,	NULL
Bob1	NULL
,	NULL
or	NULL
both	NULL
NF-B	NULL
subunits	NULL
p50	NULL
and	NULL
p52	NULL
.	NULL

In	NULL
all	NULL
of	NULL
these	NULL
animals	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
BLR1	NULL
was	NULL
reduced	NULL
or	NULL
absent	NULL
.	NULL

In	NULL
mice	NULL
deficient	NULL
only	NULL
of	NULL
p52/NF	NULL
-B	NULL
,	NULL
BLR1	NULL
expression	NULL
was	NULL
unaffected	NULL
.	NULL

Thus	NULL
our	NULL
data	NULL
demonstrate	NULL
that	NULL
BLR1	NULL
is	NULL
a	NULL
target	NULL
gene	NULL
for	NULL
Oct-2	NULL
,	NULL
Bob1l	NULL
,	NULL
and	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
and	NULL
provides	NULL
a	NULL
link	NULL
to	NULL
the	NULL
impaired	NULL
B	NULL
cell	NULL
functions	NULL
in	NULL
mice	NULL
deficient	NULL
for	NULL
these	NULL
factors	NULL
.	NULL

BLRL/CXCRS5	NULL
is	NULL
the	NULL
receptor	NULL
of	NULL
the	NULL
recently	NULL
identified	NULL
CXC	NULL
chemokine	NULL
BCA-1/BLC	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
of	NULL
human	NULL
BLR1I	NULL
was	NULL
originally	NULL
isolated	NULL
from	NULL
a	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
3	NULL
)	NULL
,	NULL
and	NULL
its	NULL
homologues	NULL
were	NULL
cloned	NULL
from	NULL
murine	NULL
and	NULL
rat	NULL
tissues	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
BLR1	NULL
is	NULL
restricted	NULL
to	NULL
mature	NULL
resting	NULL
B	NULL
cells	NULL
and	NULL
a	NULL
subset	NULL
of	NULL
T	NULL
helper	NULL
memory	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
birJ	NULL
gene	NULL
in	NULL
mice	NULL
revealed	NULL
an	NULL
essential	NULL
role	NULL
of	NULL
this	NULL
receptor	NULL
in	NULL
directing	NULL
lymphocyte	NULL
migration	NULL
(	NULL
7	NULL
)	NULL
.	NULL

BirZ'~	NULL
mice	NULL
lack	NULL
inguinal	NULL
lymph	NULL
nodes	NULL
and	NULL
possess	NULL
either	NULL
none	NULL
or	NULL
a	NULL
significantly	NULL
reduced	NULL
number	NULL
of	NULL
morpho-logically	NULL
altered	NULL
Peyer	NULL
's	NULL
patches	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
B	NULL
cells	NULL
to	NULL
Peyer	NULL
's	NULL
patches	NULL
and	NULL
splenic	NULL
follicles	NULL
was	NULL
severely	NULL
impaired	NULL
in	NULL
these	NULL
animals	NULL
,	NULL
resulting	NULL
in	NULL
significant	NULL
morphological	NULL
alterations	NULL
of	NULL
the	NULL
primary	NULL
lymphoid	NULL
follicles	NULL
and	NULL
lack	NULL
of	NULL
functional	NULL
germinal	NULL
centers	NULL
.	NULL

The	NULL
regulatory	NULL
mechanisms	NULL
directing	NULL
cell	NULL
type-	NULL
and	NULL
differen-	NULL
*	NULL
This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
Grants	NULL
Fa	NULL
188/4-7	NULL
and	NULL
Li	NULL
374/8-1	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
``	NULL
``	NULL
/EBI	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
X83755	NULL
and	NULL
X83756	NULL
.	NULL

4	NULL
These	NULL
authors	NULL
contributed	NULL
as	NULL
equal	NULL
first	NULL
authors	NULL
to	NULL
this	NULL
work	NULL
.	NULL

|	NULL
Present	NULL
address	NULL
:	NULL
Fred	NULL
Hutchinson	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
1124	NULL
Columbia	NULL
St.	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98104	NULL
.	NULL

**	NULL
Supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
Boehringer	NULL
Ingelheim	NULL
Fonds	NULL
.	NULL

§§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

E-mail	NULL
:	NULL
mLIPP	NULL
@	NULL
mdec-berlin.de	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
tiation-specific	NULL
expression	NULL
of	NULL
genes	NULL
to	NULL
mature	NULL
B	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
resolved	NULL
.	NULL

Candidate	NULL
transcription	NULL
factors	NULL
are	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
that	NULL
includes	NULL
several	NULL
factors	NULL
;	NULL
among	NULL
these	NULL
a	NULL
heterodimer	NULL
of	NULL
p50	NULL
(	NULL
NFxB1	NULL
)	NULL
and	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
is	NULL
one	NULL
of	NULL
the	NULL
prevailing	NULL
forms	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

All	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
share	NULL
a	NULL
common	NULL
amino-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
dimerization	NULL
as	NULL
well	NULL
as	NULL
for	NULL
DNA	NULL
binding	NULL
.	NULL

Upon	NULL
induction	NULL
by	NULL
various	NULL
stimuli	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
activate	NULL
a	NULL
wide	NULL
array	NULL
of	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
involved	NULL
in	NULL
the	NULL
early	NULL
immune	NULL
response	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Ref	NULL
.	NULL

8	NULL
)	NULL
.	NULL

The	NULL
octamer	NULL
consensus	NULL
sequence	NULL
,	NULL
5-ATGCAAAT-3	NULL
'	NULL
,	NULL
was	NULL
initially	NULL
identified	NULL
as	NULL
an	NULL
essential	NULL
regulatory	NULL
element	NULL
in	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
the	NULL
immunoglobulin	NULL
genes	NULL
but	NULL
is	NULL
also	NULL
present	NULL
in	NULL
promoters	NULL
of	NULL
numerous	NULL
ubiquitous	NULL
genes	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Ref	NULL
.	NULL

9	NULL
)	NULL
.	NULL

The	NULL
octamer	NULL
motif	NULL
is	NULL
recognized	NULL
by	NULL
the	NULL
ubiquitously	NULL
expressed	NULL
transcription	NULL
factor	NULL
Oct-1	NULL
and	NULL
by	NULL
the	NULL
B	NULL
lymphocyte-restricted	NULL
factor	NULL
Oct-2	NULL
.	NULL

Both	NULL
are	NULL
highly	NULL
homologous	NULL
in	NULL
their	NULL
bipartite	NULL
DNA-binding	NULL
POU	NULL
domain	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Ref	NULL
.	NULL

10	NULL
)	NULL
.	NULL

As	NULL
both	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
bind	NULL
equally	NULL
well	NULL
to	NULL
the	NULL
octamer	NULL
sequence	NULL
,	NULL
it	NULL
remains	NULL
unclear	NULL
whether	NULL
Oct-2	NULL
specifically	NULL
directs	NULL
the	NULL
expression	NULL
of	NULL
octamer-dependent	NULL
genes	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Several	NULL
observations	NULL
suggest	NULL
the	NULL
existence	NULL
of	NULL
additional	NULL
B	NULL
cell-re-stricted	NULL
cofactors	NULL
essential	NULL
for	NULL
an	NULL
octamer-dependent	NULL
gene	NULL
activation	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
novel	NULL
B	NULL
cell-specific	NULL
coactivator	NULL
of	NULL
octamer	NULL
binding	NULL
factors	NULL
termed	NULL
Bobl	NULL
(	NULL
OBF-L/OCA-B	NULL
)	NULL
was	NULL
identified	NULL
and	NULL
cloned	NULL
from	NULL
human	NULL
(	NULL
11-13	NULL
)	NULL
and	NULL
murine	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
tissues	NULL
.	NULL

Bob1l	NULL
interacts	NULL
with	NULL
the	NULL
POU	NULL
domains	NULL
of	NULL
either	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
forming	NULL
a	NULL
ternary	NULL
complex	NULL
on	NULL
DNA	NULL
.	NULL

Upon	NULL
the	NULL
binding	NULL
of	NULL
Bob1	NULL
,	NULL
Oct-1	NULL
is	NULL
converted	NULL
from	NULL
an	NULL
ubiquitous	NULL
to	NULL
a	NULL
lymphocyte-specific	NULL
factor	NULL
and	NULL
shows	NULL
increased	NULL
specificity	NULL
of	NULL
DNA	NULL
binding	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Although	NULL
in	NULL
gene-targeted	NULL
mice	NULL
Oct-2	NULL
is	NULL
dispensable	NULL
in	NULL
the	NULL
antigen-independent	NULL
stage	NULL
of	NULL
B	NULL
lymphocyte	NULL
development	NULL
,	NULL
B	NULL
cell	NULL
maturation	NULL
seems	NULL
to	NULL
be	NULL
severely	NULL
impaired	NULL
in	NULL
these	NULL
animals	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
two	NULL
Oct-2-regulated	NULL
genes	NULL
,	NULL
CD36	NULL
(	NULL
18	NULL
)	NULL
and	NULL
CRISP-3	NULL
(	NULL
19	NULL
)	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

As	NULL
their	NULL
function	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
there	NULL
might	NULL
be	NULL
yet	NULL
undiscovered	NULL
targets	NULL
of	NULL
Oct-2	NULL
regulation	NULL
that	NULL
are	NULL
relevant	NULL
for	NULL
B	NULL
cell	NULL
matura-tion	NULL
.	NULL

Data	NULL
presented	NULL
here	NULL
demonstrate	NULL
that	NULL
in	NULL
B	NULL
cells	NULL
regulation	NULL
of	NULL
the	NULL
BLR1I	NULL
gene	NULL
is	NULL
cooperatively	NULL
controlled	NULL
by	NULL
NF-KB	NULL
,	NULL
Oct-2	NULL
,	NULL
and	NULL
Bob1	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
the	NULL
B	NULL
cell	NULL
homing	NULL
chemokine	NULL
receptor	NULL
,	NULL
BLR1	NULL
,	NULL
is	NULL
a	NULL
target	NULL
for	NULL
Bobl	NULL
and	NULL
Oct-2	NULL
links	NULL
these	NULL
factors	NULL
to	NULL
the	NULL
molecule	NULL
with	NULL
an	NULL
essential	NULL
function	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Genomic	NULL
Cloning-Human	NULL
genomic	NULL
clones	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
library	NULL
made	NULL
from	NULL
genomic	NULL
DNA	NULL
of	NULL
the	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
BL64	NULL
in	NULL
the	NULL
vector	NULL
EMBL3A	NULL
(	NULL
20	NULL
)	NULL
;	NULL
murine	NULL
clones	NULL
were	NULL
isolated	NULL
from	NULL
28831	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
28832	NULL
BALB/c	NULL
(	NULL
CLONTECH	NULL
]	NULL
)	NULL
and	NULL
1295V	NULL
genomic	NULL
DNA	NULL
libraries	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Primer	NULL
Extension	NULL
and	NULL
Reverse	NULL
Transcriptase-Polymerase	NULL
Chain	NULL
Re-action-Primer	NULL
extension	NULL
was	NULL
performed	NULL
by	NULL
annealing	NULL
50	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
with	NULL
1	NULL
fmol	NULL
of	NULL
*°P-labeled	NULL
oligonucleotide	NULL
primer	NULL
TTGAGAGGCTCC-3	NULL
'	NULL
(	NULL
+212	NULL
to	NULL
+231	NULL
bp	NULL
)	NULL
``	NULL
at	NULL
42	NULL
°C	NULL
.	NULL

As	NULL
a	NULL
size	NULL
standard	NULL
,	NULL
the	NULL
genomic	NULL
2.1-kilobase	NULL
pair	NULL
BamHI	NULL
fragment	NULL
was	NULL
sequenced	NULL
with	NULL
the	NULL
same	NULL
oligonucleotide	NULL
primer	NULL
.	NULL

Reverse	NULL
transcriptase-PCR	NULL
was	NULL
performed	NULL
using	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
Raji	NULL
or	NULL
ESIII	NULL
cells	NULL
and	NULL
the	NULL
oligonucleotides	NULL
as	NULL
follows	NULL
:	NULL
primer	NULL
for	NULL
reverse	NULL
transcriptase	NULL
reaction	NULL
OT2	NULL
(	NULL
5'-GGTCCATTTCCAGCGTTAGC-3	NULL
'	NULL
)	NULL
;	NULL
3'-primer	NULL
OS2	NULL
(	NULL
5'-GGCTG-TGAGTCACCAGACTG-3	NULL
'	NULL
)	NULL
;	NULL
5'-primer	NULL
O+1	NULL
(	NULL
5-CCGGGAAAGAAGCT-GAAATG-3	NULL
'	NULL
)	NULL
;	NULL
5'-primer	NULL
O-56	NULL
(	NULL
5'-GGAGAAGTGAGGGCAGCCTTT-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
genomic	NULL
2.l1-kilobase	NULL
pair	NULL
BamHI	NULL
fragment	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Plasmid	NULL
Constructions	NULL
and	NULL
Site-directed	NULL
Mutagenesis-The	NULL
human	NULL
p-1097/+215	NULL
construct	NULL
was	NULL
made	NULL
by	NULL
ligating	NULL
the	NULL
genomic	NULL
1.29-kilo-base	NULL
pair	NULL
BamHUVXbal	NULL
fragment	NULL
with	NULL
the	NULL
double-stranded	NULL
Xbal-di-gested	NULL
oligonucleotide	NULL
(	NULL
+199	NULL
to	NULL
+215	NULL
bp	NULL
)	NULL
and	NULL
cloning	NULL
together	NULL
into	NULL
the	NULL
BamHI	NULL
and	NULL
Sail	NULL
site	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
vector	NULL
pGCAT-C	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Using	NULL
Bal-31	NULL
exonuclease	NULL
a	NULL
series	NULL
of	NULL
5'-deletion	NULL
mutants	NULL
was	NULL
prepared	NULL
.	NULL

Murine	NULL
mblrl-Luc	NULL
construct	NULL
was	NULL
made	NULL
by	NULL
cloning	NULL
the	NULL
0.98-kilobase	NULL
pair	NULL
BamHIV/Pst	NULL
]	NULL
fragment	NULL
from	NULL
129SV	NULL
genomic	NULL
DNA	NULL
into	NULL
the	NULL
pGL2-basic	NULL
luciferase	NULL
reporter	NULL
construct	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Expression	NULL
vectors	NULL
,	NULL
pCATCH-Bob1	NULL
(	NULL
11	NULL
)	NULL
and	NULL
pOEV1	NULL
(	NULL
22	NULL
)	NULL
,	NULL
were	NULL
a	NULL
gift	NULL
from	NULL
W.	NULL
Schaffner	NULL
(	NULL
Ziirich	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

Plasmids	NULL
ReCMVp50	NULL
and	NULL
ReCMVp65	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
P.	NULL
Baeuerle	NULL
(	NULL
Freiburg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

All	NULL
mutated	NULL
constructs	NULL
were	NULL
made	NULL
by	NULL
PCR-based	NULL
site-directed	NULL
mutagenesis	NULL
and	NULL
controlled	NULL
by	NULL
sequencing	NULL
.	NULL

Cell	NULL
Culture	NULL
,	NULL
DNA	NULL
Transfection	NULL
,	NULL
and	NULL
Reporter	NULL
Assays-B	NULL
cell	NULL
lines	NULL
(	NULL
Raji	NULL
,	NULL
lymphoblastoid	NULL
line	NULL
IARC549	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
AbV/Oct2-ER	NULL
)	NULL
and	NULL
Helia	NULL
cells	NULL
were	NULL
grown	NULL
at	NULL
standard	NULL
conditions	NULL
.	NULL

Hela	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5-20	NULL
pug	NULL
of	NULL
various	NULL
reporter	NULL
constructs	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
.	NULL

Raji	NULL
and	NULL
Abl/Oct2-ER	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electro-poration	NULL
(	NULL
1070	NULL
microfarads	NULL
and	NULL
250-8300	NULL
V	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
lysed	NULL
with	NULL
reporter	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
expressed	NULL
CAT	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
CAT-enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
system	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
a	NULL
LB	NULL
9501	NULL
luminometer	NULL
(	NULL
Berthold	NULL
)	NULL
using	NULL
a	NULL
luciferase	NULL
assay	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
level	NULL
of	NULL
total	NULL
cellular	NULL
protein	NULL
(	NULL
Bradford	NULL
assay	NULL
,	NULL
Bio-Rad	NULL
)	NULL
and	NULL
repeated	NULL
at	NULL
least	NULL
three	NULL
times	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays-Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
cells	NULL
depleted	NULL
of	NULL
BLR1l-expressing	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
using	NULL
a	NULL
MACS	NULL
separator	NULL
as	NULL
described	NULL
before	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
labeled	NULL
by	NULL
filling	NULL
in	NULL
the	NULL
overhangs	NULL
with	NULL
Taq	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
radioactive	NULL
NTPs	NULL
at	NULL
54	NULL
°C	NULL
.	NULL

80	NULL
fmol	NULL
were	NULL
used	NULL
per	NULL
lane	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Oligonucleotides	NULL
for	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
had	NULL
the	NULL
following	NULL
sequences	NULL
(	NULL
top	NULL
strand	NULL
)	NULL
:	NULL
Oct	NULL
,	NULL
5-GCAGCTCATTTGCTTAAATTTC	NULL
;	NULL
Oct-wt	NULL
,	NULL
5	NULL
-ATTCAG-AAAGCTCATTTGCATTAAGACCAAGCTGCAAGCTTAGC	NULL
;	NULL
Oct-m	NULL
,	NULL
5'-ATTCAGAAAGCTCACTGATACTAAGAGGAAGCTGCAAGCTTAGC	NULL
;	NULL
E-box	NULL
,	NULL
5'-tegaTCTAGAGGCACCTGGCGGGGAGC	NULL
.	NULL

Flow	NULL
Cytometry	NULL
Analysis-Lymphocytes	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
spleen	NULL
of	NULL
mice	NULL
at	NULL
4-6	NULL
weeks	NULL
except	NULL
for	NULL
progenies	NULL
of	NULL
Oct-2*	NULL
``	NULL
~	NULL
mice	NULL
that	NULL
were	NULL
isolated	NULL
within	NULL
1	NULL
h	NULL
after	NULL
delivery	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
anti-B220-fluorescein	NULL
isothiocyanate	NULL
(	NULL
Caltac	NULL
)	NULL
and	NULL
anti-BLR1-biotin	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
7	NULL
)	NULL
or	NULL
with	NULL
anti-IgM-fluorescein	NULL
isothio-cyanate	NULL
,	NULL
B220-phycoerythrin	NULL
,	NULL
and	NULL
anti-BLR1-biotin	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

After	NULL
two	NULL
washes	NULL
,	NULL
the	NULL
biotinylated	NULL
antibody	NULL
was	NULL
revealed	NULL
with	NULL
strepta-vidin-phycoerythrin	NULL
(	NULL
Jackson	NULL
ImmunoResearch	NULL
)	NULL
or	NULL
with	NULL
streptavidin-Cy-Chrome**	NULL
(	NULL
Pharmingen	NULL
)	NULL
staining	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
the	NULL
flow	NULL
cytometry	NULL
analysis	NULL
using	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

RESULTS	NULL
The	NULL
TATA-less	NULL
Human	NULL
BLR1	NULL
Promoter	NULL
Directs	NULL
RNA	NULL
Initiation	NULL
to	NULL
a	NULL
Single	NULL
Start	NULL
Site-Following	NULL
the	NULL
determination	NULL
of	NULL
the	NULL
BLR1	NULL
gene	NULL
structure	NULL
(	NULL
8	NULL
,	NULL
4	NULL
)	NULL
,	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
was	NULL
subcloned	NULL
and	NULL
sequenced	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
a	NULL
specific	NULL
single	NULL
start	NULL
site	NULL
of	NULL
the	NULL
BLR1I	NULL
transcript	NULL
was	NULL
observed	NULL
using	NULL
RNA	NULL
from	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
Raji	NULL
.	NULL

The	NULL
loca-	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
4-OHT	NULL
,	NULL
4-hydroxyta-moxifen	NULL
;	NULL
FPR	NULL
,	NULL
functional	NULL
promoter	NULL
region	NULL
.	NULL

Oct-2-dependent	NULL
Expression	NULL
of	NULL
BLR1	NULL
A	NULL
totai	NULL
RNA	NULL
A\	NULL
Rajl	NULL
A	NULL
C	NULL
G	NULL
T	NULL
A	NULL
A	NULL
»	NULL
H	NULL
g	NULL
a	NULL
:	NULL
a1	NULL
-an	NULL
-	NULL
|	NULL
work	NULL
Ene	NULL
:	NULL
e	NULL
jw	NULL
ATG	NULL
g	NULL
-as	NULL
,	NULL
+267	NULL
G	NULL
new	NULL
A	NULL
-*-	NULL
yams	NULL
A	NULL
~*	NULL
_	NULL
ams	NULL
A	NULL
G	NULL
e	NULL
_-A	NULL
A	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
RNA	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
human	NULL
BLR1I	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
primer	NULL
extension	NULL
was	NULL
performed	NULL
with	NULL
50	NULL
ug	NULL
of	NULL
total	NULL
Raji	NULL
cells	NULL
RNA	NULL
hybridized	NULL
to	NULL
a	NULL
*°P-labeled	NULL
primer	NULL
complementary	NULL
to	NULL
nucleotides	NULL
+212	NULL
to	NULL
+281	NULL
bp	NULL
.	NULL

The	NULL
precise	NULL
position	NULL
of	NULL
the	NULL
5'-end	NULL
was	NULL
determined	NULL
by	NULL
electrophoresis	NULL
of	NULL
the	NULL
primer	NULL
extension	NULL
products	NULL
next	NULL
to	NULL
a	NULL
sequence	NULL
ladder	NULL
derived	NULL
from	NULL
the	NULL
same	NULL
primer	NULL
.	NULL

B	NULL
,	NULL
PCR	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
total	NULL
Raji	NULL
RNA	NULL
or	NULL
genomic	NULL
DNA	NULL
.	NULL

M	NULL
,	NULL
123-bp	NULL
ladder	NULL
;	NULL
K1	NULL
,	NULL
no	NULL
reverse	NULL
transcriptase	NULL
was	NULL
added	NULL
;	NULL
K2	NULL
,	NULL
no	NULL
DNA	NULL
was	NULL
added	NULL
.	NULL

tion	NULL
of	NULL
the	NULL
start	NULL
site	NULL
could	NULL
be	NULL
confirmed	NULL
by	NULL
PCR	NULL
analysis	NULL
using	NULL
primers	NULL
flanking	NULL
the	NULL
initiation	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Only	NULL
primer	NULL
pair	NULL
1	NULL
(	NULL
O+1	NULL
,	NULL
sequence	NULL
+1	NULL
to	NULL
+20	NULL
bp	NULL
)	NULL
generated	NULL
a	NULL
PCR	NULL
product	NULL
on	NULL
the	NULL
RNA	NULL
template	NULL
,	NULL
whereas	NULL
primer	NULL
pair	NULL
2	NULL
(	NULL
0-56	NULL
,	NULL
sequence	NULL
-56	NULL
to	NULL
-36	NULL
bp	NULL
)	NULL
did	NULL
not	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
PCR	NULL
was	NULL
done	NULL
on	NULL
a	NULL
DNA	NULL
template	NULL
using	NULL
both	NULL
primer	NULL
pairs	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Alignment	NULL
of	NULL
the	NULL
nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
BLR1I	NULL
promoter	NULL
(	NULL
EMBL	NULL
accession	NULL
no	NULL
.	NULL

X83755	NULL
)	NULL
and	NULL
its	NULL
murine	NULL
counterpart	NULL
(	NULL
EMBL	NULL
accession	NULL
no	NULL
.	NULL

X83756	NULL
)	NULL
shows	NULL
highly	NULL
conserved	NULL
regions	NULL
that	NULL
include	NULL
consensus	NULL
sequences	NULL
for	NULL
potential	NULL
regulatory	NULL
elements	NULL
such	NULL
as	NULL
APL	NULL
,	NULL
LEF-1	NULL
,	NULL
NF-kB	NULL
,	NULL
a	NULL
purine-rich	NULL
sequence	NULL
(	NULL
Pu.box	NULL
)	NULL
,	NULL
a	NULL
noncanonical	NULL
octamer	NULL
,	NULL
and	NULL
an	NULL
E-box	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Both	NULL
promoters	NULL
lack	NULL
TATA	NULL
and	NULL
CCAAT	NULL
boxes	NULL
as	NULL
well	NULL
as	NULL
initiator-like	NULL
sequences	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Cell	NULL
Type	NULL
and	NULL
Differentiation	NULL
Stage	NULL
Specificity	NULL
of	NULL
BLR1	NULL
Promoter	NULL
Activity-To	NULL
define	NULL
the	NULL
sequences	NULL
responsible	NULL
for	NULL
cell	NULL
type-	NULL
and	NULL
differentiation-specific	NULL
BLR1I	NULL
expression	NULL
,	NULL
a	NULL
series	NULL
of	NULL
5'-deletion	NULL
mutants	NULL
of	NULL
the	NULL
human	NULL
promoter	NULL
region	NULL
starting	NULL
at	NULL
position	NULL
-1097	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
and	NULL
transfected	NULL
into	NULL
Raji	NULL
,	NULL
IARC549	NULL
,	NULL
or	NULL
Hela	NULL
cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CAT	NULL
expression	NULL
driven	NULL
from	NULL
the	NULL
BLR1	NULL
promoter	NULL
was	NULL
only	NULL
detectable	NULL
in	NULL
Raji	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
IARC549	NULL
or	NULL
Hela	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
murine	NULL
birl	NULL
promoter	NULL
cloned	NULL
into	NULL
the	NULL
luciferase	NULL
reporter	NULL
vector	NULL
mblrl-Lue	NULL
was	NULL
consistently	NULL
active	NULL
in	NULL
Raji	NULL
but	NULL
not	NULL
in	NULL
Hela	NULL
cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
minimal	NULL
5'-deletion	NULL
construct	NULL
p-78/+215	NULL
retained	NULL
cell	NULL
type-specific	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
regulatory	NULL
elements	NULL
lying	NULL
within	NULL
positions	NULL
-78	NULL
and	NULL
+215	NULL
are	NULL
sufficient	NULL
to	NULL
confer	NULL
basal	NULL
activity	NULL
as	NULL
well	NULL
as	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
the	NULL
BLR1	NULL
promoter	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
regulatory	NULL
motifs	NULL
essential	NULL
for	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
introduced	NULL
a	NULL
variety	NULL
of	NULL
mutations	NULL
into	NULL
the	NULL
wild-type	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Oct-2-dependent	NULL
Expression	NULL
of	NULL
BLR1	NULL
28833	NULL
A	NULL
AP1	NULL
LEF-1	NULL
Pu.box	NULL
_	NULL
NF-	NULL
«	NULL
BI|	NULL
FPR	NULL
NF-	NULL
«	NULL
BiII	NULL
Oct	NULL
E-box	NULL
mutation	NULL
M1	NULL
¢	NULL
§2¢	NULL
-	NULL
2	NULL
§§	NULL
f	NULL
``	NULL
$	NULL
#	NULL
O	NULL
``	NULL
ff	NULL
``	NULL
60	NULL
Ho	NULL
_	NULL
``	NULL
i	NULL
TI	NULL
(	NULL
=	NULL
``	NULL
$	NULL
fo_	NULL
Hf	NULL
``	NULL
H	NULL
f	NULL
*	NULL
4T	NULL
human	NULL
--	NULL
TreaGTCA	NULL
``	NULL
~	NULL
CCpPTGAA	NULL
-*-	NULL
GGGGTPPCccA	NULL
-*-	NULL
GAGGAA	NULL
-*-	NULL
cea	NULL
@	NULL
rmpcee	NULL
-*-	NULL
GA—GGGCAGCCMT	NULL
‘	NULL
LT—	NULL
GecaATTTICCc	NULL
-*-	NULL
TCATTTGCTT	NULL
``	NULL
*-	NULL
CACCTG	NULL
murine	NULL
--	NULL
TTGAGTCA	NULL
--	NULL
CCTPTGAA	NULL
-*-	NULL
GGGGTPTCCCA	NULL
-*-	NULL
AAGGAA	NULL
--	NULL
GGAGPTCCCC	NULL
-*-	NULL
GAGGGGCAGCCTTC	NULL
--	NULL
-	NULL
GGGAGTTTCCC	NULL
-*-	NULL
TCATTTGTTT	NULL
-*-	NULL
CaCGTG	NULL
mutation	NULL
3	NULL
:	NULL
GAccccA	NULL
2	NULL
B	NULL
\	NULL
A68	NULL
,	NULL
g	NULL
D	NULL
A\	NULL
C	NULL
(	NULL
ARR	NULL
CS	NULL
x	NULL
«	NULL
S	NULL
€	NULL
¢	NULL
«	NULL
oC	NULL
EXP	NULL
12	NULL
&	NULL
i-	NULL
#	NULL
-	NULL
>	NULL
-	NULL
CAT	NULL
Abl/Oct2-ER	NULL
CAT	NULL
€	NULL
CAT	NULL
E	NULL
g	NULL
8	NULL
©	NULL
$	NULL
S	NULL
E	NULL
3	NULL
4	NULL
®	NULL
0	NULL
0	NULL
50	NULL
100	NULL
150	NULL
=	NULL
=	NULL
Bob1	NULL
Bob1	NULL
C	NULL
relative	NULL
CAT	NULL
expression	NULL
[	NULL
%	NULL
]	NULL
E	NULL
=	NULL
Oct2	NULL
=	NULL
Oct2	NULL
Abl/Oct2-ER	NULL
o	NULL
2	NULL
no	NULL
lrad	NULL
relative	NULL
luciferase	NULL
activity	NULL
4a	NULL
P	NULL
o-=	NULL
=	NULL
=	NULL
4-OHT	NULL
4-OHT	NULL
4-O0HT	NULL
=-	NULL
Bob1	NULL
_	NULL
>	NULL
--	NULL
-	NULL
Bob1	NULL
-	NULL
-_	NULL
Bob1	NULL
Bob1	NULL
=	NULL
NFB	NULL
_	NULL
NFkB	NULL
=	NULL
NFB	NULL
-	NULL
NFB	NULL
=	NULL
--	NULL
-	NULL
Ocff	NULL
-	NULL
Oct	NULL
?	NULL

Oct	NULL
?	NULL

-	NULL
-	NULL
Oct	NULL
?	NULL

=	NULL
=	NULL
Bob1	NULL
=	NULL
=	NULL
Bob1	NULL
h	NULL
=	NULL
--	NULL
NFkB	NULL
_	NULL
--	NULL
NFxB	NULL
NFB	NULL
NFB	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Structural	NULL
and	NULL
functional	NULL
analyses	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
BLR1I	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
sequence	NULL
comparison	NULL
between	NULL
binding	NULL
sites	NULL
of	NULL
different	NULL
transcription	NULL
factors	NULL
in	NULL
human	NULL
BLR	NULL
]	NULL
and	NULL
murine	NULL
birl	NULL
promoters	NULL
.	NULL

Changed	NULL
nucleotides	NULL
in	NULL
the	NULL
mutated	NULL
constructs	NULL
are	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
on	NULL
the	NULL
left	NULL
are	NULL
schematic	NULL
drawings	NULL
of	NULL
the	NULL
mutated	NULL
BLRI-CAT	NULL
fusion	NULL
constructs	NULL
.	NULL

Each	NULL
mutation	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
black	NULL
symbol	NULL
.	NULL

The	NULL
wild-type	NULL
p-612/+215	NULL
and	NULL
mutated	NULL
constructs	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
Raji	NULL
cells	NULL
.	NULL

CAT	NULL
expression	NULL
was	NULL
measured	NULL
,	NULL
and	NULL
the	NULL
level	NULL
of	NULL
p-612/+215	NULL
CAT	NULL
expression	NULL
was	NULL
set	NULL
to	NULL
100	NULL
%	NULL
.	NULL

C	NULL
,	NULL
Oct-2-	NULL
,	NULL
NF-	NULL
«	NULL
B-	NULL
,	NULL
and	NULL
Bobl-dependent	NULL
activation	NULL
of	NULL
the	NULL
murine	NULL
birZ	NULL
promoter	NULL
.	NULL

20	NULL
ug	NULL
of	NULL
mbir-Lue	NULL
plasmid	NULL
or	NULL
constructs	NULL
m-E8	NULL
and	NULL
mE8-2	NULL
with	NULL
a	NULL
mutated	NULL
octamer	NULL
sequence	NULL
were	NULL
transfected	NULL
or	NULL
cotransfected	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p50/p65	NULL
(	NULL
5	NULL
ug	NULL
each	NULL
)	NULL
and	NULL
Bob1	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
in	NULL
Abl/Oct2-ER	NULL
cells	NULL
.	NULL

Each	NULL
transfection	NULL
was	NULL
split	NULL
in	NULL
half	NULL
,	NULL
and	NULL
4-O0HT	NULL
was	NULL
added	NULL
to	NULL
one	NULL
part	NULL
of	NULL
the	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
uM	NULL
where	NULL
indicated	NULL
.	NULL

Activity	NULL
of	NULL
mblrl-Lue	NULL
,	NULL
m-E8	NULL
,	NULL
or	NULL
mE8-2	NULL
alone	NULL
was	NULL
set	NULL
to	NULL
1	NULL
in	NULL
all	NULL
experiments	NULL
,	NULL
and	NULL
the	NULL
other	NULL
bars	NULL
present	NULL
data	NULL
of	NULL
six	NULL
independent	NULL
experiments	NULL
as	NULL
-fold	NULL
activation	NULL
of	NULL
luciferase	NULL
activity	NULL
above	NULL
that	NULL
.	NULL

D	NULL
,	NULL
cotransfection	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
mblr-Lue	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
pOEV1	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
pCATCH-Bob1	NULL
,	NULL
or	NULL
with	NULL
both	NULL
vectors	NULL
into	NULL
Abl/Oct2-ER	NULL
cells	NULL
.	NULL

£	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
bir1	NULL
promoter	NULL
in	NULL
Helia	NULL
cells	NULL
.	NULL

mbirl-Lue	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
5-10	NULL
ug	NULL
of	NULL
constructs	NULL
expressing	NULL
transcription	NULL
factors	NULL
Oct-2	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
Bob1	NULL
.	NULL

Luciferase	NULL
activity	NULL
observed	NULL
with	NULL
mbirl-Lue	NULL
was	NULL
set	NULL
to	NULL
1.	NULL
construct	NULL
p-612/+215	NULL
.	NULL

Each	NULL
mutation	NULL
destroyed	NULL
a	NULL
single	NULL
consensus	NULL
sequence	NULL
for	NULL
a	NULL
putative	NULL
regulatory	NULL
element	NULL
.	NULL

Among	NULL
all	NULL
tested	NULL
mutations	NULL
,	NULL
only	NULL
three	NULL
dramatically	NULL
decreased	NULL
the	NULL
level	NULL
of	NULL
CAT	NULL
expression	NULL
in	NULL
Raji	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

All	NULL
of	NULL
them	NULL
lie	NULL
within	NULL
the	NULL
region	NULL
identified	NULL
as	NULL
essential	NULL
for	NULL
promoter	NULL
activity	NULL
and	NULL
specificity	NULL
(	NULL
-78	NULL
to	NULL
+215	NULL
)	NULL
.	NULL

Mutation	NULL
B6	NULL
reduced	NULL
promoter	NULL
activity	NULL
by	NULL
80	NULL
%	NULL
.	NULL

However	NULL
,	NULL
we	NULL
could	NULL
not	NULL
specify	NULL
the	NULL
proteins	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
and	NULL
named	NULL
it	NULL
a	NULL
``	NULL
functional	NULL
promoter	NULL
region	NULL
``	NULL
(	NULL
FPR	NULL
)	NULL
,	NULL
implying	NULL
that	NULL
it	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
functional	NULL
substitution	NULL
for	NULL
the	NULL
TATA	NULL
box	NULL
within	NULL
the	NULL
BLRI	NULL
promoter	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
Byj	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
pN7	NULL
)	NULL
caused	NULL
a	NULL
decrease	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
by	NULL
60	NULL
%	NULL
.	NULL

Using	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
,	NULL
we	NULL
could	NULL
detect	NULL
binding	NULL
of	NULL
proteins	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/rel	NULL
family	NULL
to	NULL
this	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
noncanonical	NULL
octamer	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
pES8	NULL
)	NULL
reduced	NULL
promoter	NULL
activity	NULL
by	NULL
more	NULL
than	NULL
90	NULL
%	NULL
.	NULL

To	NULL
clarify	NULL
the	NULL
role	NULL
of	NULL
factors	NULL
binding	NULL
the	NULL
octamer	NULL
site	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
luciferase	NULL
driven	NULL
by	NULL
the	NULL
murine	NULL
bir1	NULL
promoter	NULL
in	NULL
the	NULL
Oct-2	NULL
conditional	NULL
AbVOct2-ER	NULL
cell	NULL
line	NULL
.	NULL

This	NULL
murine	NULL
pre-B	NULL
cell	NULL
line	NULL
is	NULL
characterized	NULL
by	NULL
a	NULL
homozygous	NULL
mutation	NULL
of	NULL
the	NULL
endogenous	NULL
oct-2	NULL
gene	NULL
and	NULL
is	NULL
stably	NULL
transformed	NULL
with	NULL
a	NULL
construct	NULL
coding	NULL
for	NULL
a	NULL
chimera	NULL
between	NULL
Oct-2	NULL
and	NULL
the	NULL
hormone-binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
estrogen	NULL
receptor	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
this	NULL
line	NULL
transfected	NULL
with	NULL
mblrl-Luc	NULL
,	NULL
consistently	NULL
less	NULL
than	NULL
10	NULL
%	NULL
of	NULL
luciferase	NULL
activity	NULL
could	NULL
be	NULL
detected	NULL
compared	NULL
with	NULL
the	NULL
cells	NULL
with	NULL
endogenously	NULL
expressed	NULL
birl	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
4-OHT	NULL
induces	NULL
functional	NULL
activation	NULL
of	NULL
Oct-2	NULL
but	NULL
excludes	NULL
the	NULL
transactivation	NULL
by	NULL
the	NULL
hormone-binding	NULL
domain	NULL
present	NULL
in	NULL
the	NULL
Oct2-ER	NULL
fusion	NULL
protein	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
4-OHT	NULL
to	NULL
the	NULL
transfected	NULL
cells	NULL
resulted	NULL
in	NULL
an	NULL
over	NULL
5-fold	NULL
activation	NULL
of	NULL
the	NULL
bir1	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
luciferase	NULL
from	NULL
two	NULL
constructs	NULL
with	NULL
different	NULL
mutations	NULL
of	NULL
the	NULL
octamer	NULL
site	NULL
was	NULL
barely	NULL
detectable	NULL
and	NULL
could	NULL
not	NULL
be	NULL
stimulated	NULL
by	NULL
4-OHT	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

We	NULL
further	NULL
tested	NULL
the	NULL
contribution	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
as	NULL
well	NULL
as	NULL
of	NULL
Bob1	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
birl	NULL
promoter	NULL
.	NULL

Both	NULL
the	NULL
wild-type	NULL
vector	NULL
as	NULL
well	NULL
as	NULL
the	NULL
mutated	NULL
counterpart	NULL
m-E8	NULL
could	NULL
be	NULL
activated	NULL
when	NULL
cotransfected	NULL
with	NULL
vectors	NULL
expressing	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
al	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
28834	NULL
though	NULL
the	NULL
levels	NULL
of	NULL
activation	NULL
differed	NULL
and	NULL
increased	NULL
8-	NULL
and	NULL
4-fold	NULL
,	NULL
respectively	NULL
.	NULL

However	NULL
,	NULL
the	NULL
other	NULL
mutated	NULL
construct	NULL
,	NULL
m-E8-2	NULL
,	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
remained	NULL
completely	NULL
inactive	NULL
.	NULL

Bob1l	NULL
could	NULL
only	NULL
very	NULL
slightly	NULL
add	NULL
to	NULL
the	NULL
activation	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
alone	NULL
,	NULL
but	NULL
the	NULL
combinatory	NULL
action	NULL
of	NULL
Bobl	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
complemented	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
Oct-2	NULL
by	NULL
4-OHT	NULL
produced	NULL
an	NULL
over	NULL
45-fold	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
neither	NULL
of	NULL
the	NULL
mutated	NULL
vectors	NULL
showed	NULL
any	NULL
response	NULL
.	NULL

The	NULL
construct	NULL
,	NULL
m-E8	NULL
,	NULL
bears	NULL
a	NULL
single	NULL
nucleotide	NULL
substitution	NULL
at	NULL
position	NULL
5	NULL
within	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

As	NULL
reported	NULL
recently	NULL
,	NULL
this	NULL
substitution	NULL
still	NULL
permits	NULL
very	NULL
weak	NULL
residual	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
resulting	NULL
site	NULL
(	NULL
26	NULL
)	NULL
.	NULL

However	NULL
,	NULL
4	NULL
of	NULL
8	NULL
nucleotides	NULL
are	NULL
substituted	NULL
in	NULL
mutation	NULL
m-E8-2	NULL
,	NULL
thus	NULL
completely	NULL
eliminating	NULL
any	NULL
binding	NULL
to	NULL
this	NULL
region	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
,	NULL
the	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
mutation	NULL
m-E8	NULL
was	NULL
able	NULL
to	NULL
weakly	NULL
compete	NULL
for	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
sequence	NULL
from	NULL
the	NULL
birl	NULL
promoter	NULL
,	NULL
whereas	NULL
the	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
mutation	NULL
m-E8-2	NULL
did	NULL
not	NULL
compete	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
little	NULL
residual	NULL
activity	NULL
of	NULL
Oct-1	NULL
possibly	NULL
binding	NULL
to	NULL
the	NULL
mutation	NULL
m-E8	NULL
could	NULL
allow	NULL
moderate	NULL
activation	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

However	NULL
,	NULL
introduction	NULL
of	NULL
a	NULL
severe	NULL
mutation	NULL
into	NULL
the	NULL
octamer	NULL
site	NULL
completely	NULL
destroys	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
and	NULL
also	NULL
prevents	NULL
activation	NULL
by	NULL
any	NULL
other	NULL
factors	NULL
.	NULL

Similarly	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
Oct-2	NULL
by	NULL
4-OHT	NULL
,	NULL
transient	NULL
expression	NULL
of	NULL
Oct-2	NULL
resulted	NULL
in	NULL
4-fold	NULL
activation	NULL
of	NULL
the	NULL
birJ	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

The	NULL
same	NULL
level	NULL
of	NULL
induction	NULL
was	NULL
mediated	NULL
by	NULL
Bob1	NULL
alone	NULL
suggesting	NULL
that	NULL
the	NULL
ternary	NULL
complex	NULL
of	NULL
Bobl	NULL
and	NULL
the	NULL
ubiquitous	NULL
factor	NULL
Oct-1	NULL
can	NULL
substitute	NULL
for	NULL
Oct-2	NULL
in	NULL
AbVOct2-ER	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
strongest	NULL
activation	NULL
(	NULL
approximately	NULL
9-fold	NULL
)	NULL
is	NULL
produced	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
Bobl	NULL
and	NULL
Oct-2	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

As	NULL
mentioned	NULL
above	NULL
,	NULL
no	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
was	NULL
detected	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
the	NULL
birl	NULL
promoter	NULL
exerts	NULL
activity	NULL
in	NULL
the	NULL
Hela	NULL
cell	NULL
line	NULL
upon	NULL
ectopical	NULL
expression	NULL
of	NULL
Oct-2A	NULL
,	NULL
NF	NULL
-B	NULL
,	NULL
and	NULL
Bob1	NULL
(	NULL
Fig	NULL
.	NULL

25	NULL
)	NULL
.	NULL

Neither	NULL
of	NULL
the	NULL
latter	NULL
factors	NULL
could	NULL
strongly	NULL
activate	NULL
the	NULL
reporter	NULL
expression	NULL
on	NULL
its	NULL
own	NULL
.	NULL

However	NULL
,	NULL
significant	NULL
transactivation	NULL
patterns	NULL
were	NULL
mediated	NULL
by	NULL
various	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
Oct-2A	NULL
,	NULL
or	NULL
Bob1l	NULL
.	NULL

The	NULL
most	NULL
striking	NULL
induction	NULL
was	NULL
achieved	NULL
with	NULL
all	NULL
three	NULL
factors	NULL
together	NULL
.	NULL

Even	NULL
in	NULL
this	NULL
case	NULL
,	NULL
however	NULL
,	NULL
the	NULL
level	NULL
of	NULL
reporter	NULL
expression	NULL
was	NULL
still	NULL
much	NULL
lower	NULL
than	NULL
that	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
additional	NULL
unidentified	NULL
B	NULL
cell-specific	NULL
activators	NULL
seem	NULL
to	NULL
be	NULL
required	NULL
for	NULL
full	NULL
promoter	NULL
function	NULL
.	NULL

Binding	NULL
of	NULL
Oct-2	NULL
Correlates	NULL
with	NULL
the	NULL
Expression	NULL
of	NULL
BLRI-As	NULL
shown	NULL
above	NULL
,	NULL
the	NULL
octamer	NULL
motif	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
BLR1I	NULL
gene	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
Oct	NULL
proteins	NULL
to	NULL
the	NULL
noncanonical	NULL
octamer	NULL
site	NULL
.	NULL

Incubation	NULL
of	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
with	NULL
Raji	NULL
nuclear	NULL
extracts	NULL
produced	NULL
several	NULL
octamer-specific	NULL
nucleoprotein	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

These	NULL
complexes	NULL
were	NULL
formed	NULL
by	NULL
the	NULL
octamer	NULL
binding	NULL
factor	NULL
Oct-1	NULL
and	NULL
two	NULL
alternatively	NULL
spliced	NULL
variants	NULL
of	NULL
Oct-2	NULL
,	NULL
Oct-2A	NULL
and	NULL
Oct-2B	NULL
,	NULL
and	NULL
could	NULL
be	NULL
specifically	NULL
competed	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
2-9	NULL
)	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
nuclear	NULL
extracts	NULL
from	NULL
lymphoblastoid	NULL
IARC549	NULL
B	NULL
cells	NULL
,	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
negative	NULL
for	NULL
BLR1	NULL
expression	NULL
(	NULL
PBL®	NULL
``	NULL
``	NULL
*'~	NULL
)	NULL
,	NULL
and	NULL
nonlymphoid	NULL
Hela	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
10-12	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
Oct-2A	NULL
and	NULL
Oct-2B	NULL
was	NULL
very	NULL
low	NULL
in	NULL
lymphoblastoid	NULL
IARC549	NULL
B	NULL
cells	NULL
,	NULL
which	NULL
represent	NULL
an	NULL
activated	NULL
stage	NULL
and	NULL
do	NULL
not	NULL
express	NULL
BLR1	NULL
,	NULL
and	NULL
was	NULL
absent	NULL
in	NULL
PBL	NULL
®	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

Other	NULL
nucleoproteins	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
determined	NULL
consensus	NULL
sequences	NULL
within	NULL
the	NULL
BLR1I	NULL
promoter	NULL
,	NULL
showed	NULL
no	NULL
differences	NULL
in	NULL
their	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
Raji	NULL
or	NULL
IARC549	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

BLR1	NULL
Expression	NULL
Is	NULL
Highly	NULL
Reduced	NULL
in	NULL
Lymphatic	NULL
Organs	NULL
of	NULL
Oct-2	NULL
,	NULL
Bob-1	NULL
,	NULL
and	NULL
p50/p52	NULL
Knockout	NULL
Mice-We	NULL
were	NULL
interested	NULL
in	NULL
testing	NULL
whether	NULL
the	NULL
expression	NULL
of	NULL
birl	NULL
would	NULL
be	NULL
affected	NULL
in	NULL
mice	NULL
deficient	NULL
for	NULL
Oct-2	NULL
.	NULL

These	NULL
mice	NULL
die	NULL
within	NULL
a	NULL
few	NULL
Oct-2-dependent	NULL
Expression	NULL
of	NULL
BLR1	NULL
Raji	NULL
Nuclear	NULL
I	NULL
%	NULL
2	NULL
a	NULL
u	NULL
a	NULL
«	NULL
l	NULL
X	NULL
X	NULL
%	NULL
%	NULL
X	NULL
%	NULL
extract	NULL
z	NULL
z	NULL
§	NULL
&	NULL
&	NULL
$	NULL
yo	NULL
y	NULL
P	NULL
tc	NULL
t	NULL
2	NULL
5	NULL
Competitor	NULL
zos	NULL
&	NULL
&	NULL
g	NULL
g	NULL
x	NULL
z	NULL
8	NULL
a	NULL
,	NULL
s	NULL
fold	NULL
molar	NULL
we	NULL
ea	NULL
wh	NULL
als	NULL
as	NULL
als	NULL
al	NULL
.	NULL

_d	NULL
(	NULL
8	NULL
6	NULL
b	NULL
5	NULL
5	NULL
5	NULL
2	NULL
2	NULL
5	NULL
m	NULL
%	NULL
excess	NULL
)	NULL
o	NULL
o	NULL
o	NULL
o	NULL
6	NULL
6	NULL
w	NULL
w	NULL
S	NULL
a	NULL
©	NULL
Oct-1	NULL
-	NULL
»	NULL
te	NULL
ie	NULL
hte	NULL
a	NULL
Oct-2B	NULL
-	NULL
»	NULL
&	NULL
O	NULL
@	NULL
#	NULL
&	NULL
-	NULL
w	NULL
eme	NULL
TYE	NULL
ns	NULL
-P	NULL
D	NULL
«	NULL
-	NULL
»	NULL
cams	NULL
came	NULL
«	NULL
as	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Specific	NULL
binding	NULL
of	NULL
octamer	NULL
binding	NULL
factors	NULL
to	NULL
the	NULL
noncanonical	NULL
octamer	NULL
site	NULL
within	NULL
the	NULL
BLR1I	NULL
promoter	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
the	NULL
octamer	NULL
binding	NULL
site	NULL
from	NULL
+152	NULL
to	NULL
+178	NULL
and	NULL
2-ug	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Raji	NULL
cells	NULL
,	NULL
IARC549	NULL
,	NULL
peripheral	NULL
BLR1-nonexpressing	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL®	NULL
``	NULL
``	NULL
*	NULL
``	NULL
~	NULL
)	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

Complexes	NULL
Oct-1	NULL
,	NULL
Oct-2A	NULL
,	NULL
and	NULL
Oct-2B	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

F	NULL
,	NULL
free	NULL
probe	NULL
;	NULL
ns	NULL
,	NULL
nonspecific	NULL
complex	NULL
.	NULL

hours	NULL
after	NULL
delivery	NULL
for	NULL
unknown	NULL
reasons	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
BLR1	NULL
in	NULL
spleen	NULL
lymphocytes	NULL
from	NULL
newborn	NULL
progeny	NULL
of	NULL
Oct-2'~-	NULL
mice	NULL
was	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

BLR1	NULL
expression	NULL
was	NULL
only	NULL
barely	NULL
detectable	NULL
on	NULL
B220	NULL
positive	NULL
cells	NULL
from	NULL
null	NULL
mutant	NULL
mice	NULL
,	NULL
whereas	NULL
cells	NULL
isolated	NULL
from	NULL
wild-type	NULL
littermates	NULL
expressed	NULL
levels	NULL
of	NULL
BLR1	NULL
usually	NULL
observed	NULL
in	NULL
newborns	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

As	NULL
the	NULL
in	NULL
vitro	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
bir1	NULL
promoter	NULL
is	NULL
fully	NULL
active	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Bobl	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
we	NULL
further	NULL
tested	NULL
the	NULL
expression	NULL
of	NULL
BLR1	NULL
in	NULL
mice	NULL
deficient	NULL
for	NULL
these	NULL
factors	NULL
.	NULL

Expression	NULL
of	NULL
BLR1	NULL
in	NULL
B220	NULL
*	NULL
cells	NULL
derived	NULL
from	NULL
lymph	NULL
nodes	NULL
or	NULL
spleen	NULL
was	NULL
unaffected	NULL
both	NULL
in	NULL
wild-type	NULL
and	NULL
heterozy-gous	NULL
animals	NULL
;	NULL
however	NULL
,	NULL
it	NULL
was	NULL
more	NULL
than	NULL
50	NULL
%	NULL
reduced	NULL
in	NULL
Bob1l	NULL
null	NULL
mutant	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
data	NULL
shown	NULL
for	NULL
lymph	NULL
nodes	NULL
only	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
expression	NULL
of	NULL
BLR1	NULL
was	NULL
virtually	NULL
absent	NULL
in	NULL
mice	NULL
lacking	NULL
both	NULL
p50	NULL
and	NULL
p52	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

Interest-ingly	NULL
,	NULL
mice	NULL
lacking	NULL
p52	NULL
only	NULL
showed	NULL
regular	NULL
levels	NULL
of	NULL
BLRL	NULL
.	NULL

DISCUSSION	NULL
We	NULL
isolated	NULL
and	NULL
characterized	NULL
the	NULL
promoter	NULL
for	NULL
the	NULL
BLR1I	NULL
gene	NULL
.	NULL

BLR1	NULL
transcription	NULL
initiation	NULL
starts	NULL
at	NULL
a	NULL
single	NULL
site	NULL
,	NULL
but	NULL
the	NULL
promoter	NULL
sequence	NULL
lacks	NULL
classical	NULL
features	NULL
like	NULL
a	NULL
TATA	NULL
box	NULL
or	NULL
an	NULL
initiator-like	NULL
sequence	NULL
.	NULL

The	NULL
core	NULL
promoter	NULL
sequence	NULL
required	NULL
for	NULL
basic	NULL
and	NULL
tissue-specific	NULL
expression	NULL
was	NULL
found	NULL
to	NULL
reside	NULL
in	NULL
a	NULL
fragment	NULL
encompassing	NULL
a	NULL
region	NULL
from	NULL
position	NULL
-78	NULL
to	NULL
+215	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

By	NULL
mu-tational	NULL
analysis	NULL
,	NULL
it	NULL
was	NULL
found	NULL
that	NULL
this	NULL
fragment	NULL
harbors	NULL
three	NULL
regions	NULL
essential	NULL
for	NULL
promoter	NULL
activity	NULL
:	NULL
1	NULL
)	NULL
a	NULL
site	NULL
termed	NULL
FPR	NULL
located	NULL
at	NULL
position	NULL
-36	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
it	NULL
may	NULL
be	NULL
important	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
preinitiation	NULL
complex	NULL
;	NULL
2	NULL
)	NULL
a	NULL
NF-kB	NULL
site	NULL
;	NULL
and	NULL
3	NULL
)	NULL
a	NULL
noncanonical	NULL
octamer	NULL
sequence	NULL
.	NULL

The	NULL
latter	NULL
is	NULL
the	NULL
key	NULL
determinant	NULL
for	NULL
BLR1I	NULL
promoter	NULL
activity	NULL
,	NULL
because	NULL
a	NULL
mutation	NULL
abrogating	NULL
binding	NULL
of	NULL
Oct	NULL
factors	NULL
resulted	NULL
in	NULL
a	NULL
complete	NULL
promoter	NULL
inactivation	NULL
.	NULL

Available	NULL
evidence	NULL
suggests	NULL
that	NULL
NF	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Oct-2-dependent	NULL
Expression	NULL
of	NULL
BLR1	NULL
oct2+/+	NULL
B	NULL
oct2~/-	NULL
rremmm	NULL
-t-mmmmic	NULL
C	NULL
-	NULL
wt	NULL
[	NULL
}	NULL
‘	NULL
,	NULL
\_a	NULL
-	NULL
wt	NULL
--	NULL
-	NULL
Bob-th	NULL
``	NULL
|	NULL
-	NULL
[	NULL
``	NULL
**A	NULL
--	NULL
-	NULL
psa	NULL
*~	NULL
--	NULL
--	NULL
--	NULL
Bob-1	NULL
/-	NULL
\	NULL
...	NULL
...	NULL
pso/	NULL
p52	NULL
7~	NULL
log10	NULL
BLR1	NULL
fluorescence	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Reduced	NULL
birl	NULL
expression	NULL
in	NULL
various	NULL
knockout	NULL
mice	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
analysis	NULL
of	NULL
BLR1	NULL
expression	NULL
in	NULL
spleen	NULL
lymphocytes	NULL
from	NULL
wild-type-	NULL
(	NULL
4	NULL
)	NULL
and	NULL
Oct-2-deficient	NULL
mice	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
gates	NULL
were	NULL
set	NULL
to	NULL
the	NULL
B220	NULL
positive	NULL
cells	NULL
.	NULL

Antibody	NULL
isotype	NULL
control	NULL
is	NULL
shown	NULL
in	NULL
gray	NULL
.	NULL

C	NULL
,	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
analysis	NULL
of	NULL
BLRL	NULL
expression	NULL
in	NULL
B220	NULL
positive	NULL
cells	NULL
taken	NULL
from	NULL
lymph	NULL
nodes	NULL
of	NULL
Bobl	NULL
knockout	NULL
,	NULL
heterozygous	NULL
,	NULL
or	NULL
wild-type	NULL
mice	NULL
as	NULL
indicated	NULL
.	NULL

Antibody	NULL
isotype	NULL
control	NULL
is	NULL
shown	NULL
in	NULL
gray	NULL
.	NULL

D	NULL
,	NULL
expression	NULL
of	NULL
BLR1	NULL
on	NULL
B220	NULL
positive	NULL
splenocytes	NULL
from	NULL
wild-type	NULL
,	NULL
p52	NULL
knockout	NULL
(	NULL
dashed	NULL
line	NULL
)	NULL
,	NULL
and	NULL
p50/p52	NULL
double	NULL
knockout	NULL
mice	NULL
(	NULL
dotted	NULL
line	NULL
)	NULL
.	NULL

«	NULL
B	NULL
,	NULL
Bobl	NULL
,	NULL
and	NULL
Oct-2	NULL
factors	NULL
act	NULL
in	NULL
a	NULL
synergistic	NULL
fashion	NULL
to	NULL
regulate	NULL
BLR1I	NULL
promoter	NULL
activity	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

It	NULL
was	NULL
reported	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
NF-kB	NULL
p50/p65	NULL
subunits	NULL
to	NULL
DNA	NULL
introduces	NULL
a	NULL
bend	NULL
into	NULL
the	NULL
DNA	NULL
molecule	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Taking	NULL
into	NULL
consideration	NULL
the	NULL
location	NULL
of	NULL
the	NULL
essential	NULL
binding	NULL
sites	NULL
for	NULL
NF-kB	NULL
,	NULL
Oct	NULL
,	NULL
and	NULL
the	NULL
FPR	NULL
in	NULL
BLR	NULL
]	NULL
1I	NULL
promoter	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
this	NULL
NF-	NULL
«	NULL
B-mediated	NULL
DNA	NULL
bending	NULL
brings	NULL
FPR	NULL
and	NULL
the	NULL
octamer	NULL
element	NULL
into	NULL
close	NULL
proximity	NULL
to	NULL
each	NULL
other	NULL
.	NULL

This	NULL
would	NULL
enable	NULL
the	NULL
interaction	NULL
of	NULL
octamer-bound	NULL
factors	NULL
to	NULL
the	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
bound	NULL
to	NULL
FPR	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
this	NULL
interaction	NULL
is	NULL
substantiated	NULL
by	NULL
the	NULL
evidence	NULL
that	NULL
Oct-2	NULL
may	NULL
facilitate	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
preinitiation	NULL
complex	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
Oct-2	NULL
can	NULL
interact	NULL
with	NULL
the	NULL
TATA	NULL
box-binding	NULL
protein	NULL
TBP	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
described	NULL
regulation	NULL
of	NULL
the	NULL
BLR1I	NULL
promoter	NULL
activity	NULL
is	NULL
the	NULL
first	NULL
example	NULL
for	NULL
the	NULL
cooperative	NULL
regulation	NULL
via	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
octamer	NULL
binding	NULL
factors	NULL
from	NULL
a	NULL
position	NULL
downstream	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
the	NULL
B	NULL
cell-specific	NULL
coactivator	NULL
Bobl	NULL
potentiates	NULL
Oct-2-mediated	NULL
activation	NULL
of	NULL
the	NULL
birl	NULL
promoter	NULL
.	NULL

Bob1	NULL
has	NULL
its	NULL
own	NULL
activation	NULL
domain	NULL
(	NULL
11	NULL
)	NULL
,	NULL
but	NULL
the	NULL
mechanism	NULL
of	NULL
activation	NULL
is	NULL
not	NULL
fully	NULL
understood	NULL
.	NULL

It	NULL
is	NULL
suggested	NULL
that	NULL
Bob1l	NULL
acts	NULL
as	NULL
a	NULL
bridge	NULL
,	NULL
connecting	NULL
the	NULL
octamer-bound	NULL
transcription	NULL
factor	NULL
to	NULL
components	NULL
of	NULL
the	NULL
TFIID	NULL
complex	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
interaction	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
BLR1I	NULL
promoter	NULL
function	NULL
.	NULL

The	NULL
ternary	NULL
complex	NULL
of	NULL
Bobl	NULL
with	NULL
octamer	NULL
factors	NULL
shows	NULL
higher	NULL
selectivity	NULL
in	NULL
recognition	NULL
of	NULL
the	NULL
octamer	NULL
sequences	NULL
,	NULL
as	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
alone	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
octamer	NULL
site	NULL
in	NULL
the	NULL
BLR1I	NULL
promoter	NULL
is	NULL
a	NULL
noncanonical	NULL
motif	NULL
,	NULL
with	NULL
a	NULL
substitution	NULL
T/A	NULL
in	NULL
the	NULL
second	NULL
position	NULL
in	NULL
the	NULL
human	NULL
promoter	NULL
accompanied	NULL
in	NULL
the	NULL
murine	NULL
counterpart	NULL
by	NULL
an	NULL
additional	NULL
substitution	NULL
G/A	NULL
in	NULL
the	NULL
third	NULL
position	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
that	NULL
the	NULL
fifth	NULL
base	NULL
in	NULL
the	NULL
octamer	NULL
28835	NULL
site	NULL
is	NULL
most	NULL
critical	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
ternary	NULL
complex	NULL
,	NULL
and	NULL
it	NULL
should	NULL
be	NULL
occupied	NULL
by	NULL
adenosine	NULL
(	NULL
16	NULL
)	NULL
.	NULL

It	NULL
was	NULL
suggested	NULL
that	NULL
the	NULL
first	NULL
three	NULL
nucleotides	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
are	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
recognition	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

However	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
birZ	NULL
promoter	NULL
is	NULL
activated	NULL
by	NULL
Bob1	NULL
,	NULL
implying	NULL
that	NULL
within	NULL
the	NULL
context	NULL
of	NULL
this	NULL
gene	NULL
the	NULL
second	NULL
and	NULL
the	NULL
third	NULL
bases	NULL
of	NULL
the	NULL
octamer	NULL
motif	NULL
are	NULL
not	NULL
necessarily	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
.	NULL

Analysis	NULL
of	NULL
mice	NULL
with	NULL
targeted	NULL
deletion	NULL
of	NULL
Oct-2	NULL
,	NULL
Bob1	NULL
,	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
provides	NULL
further	NULL
evidence	NULL
for	NULL
the	NULL
critical	NULL
requirement	NULL
of	NULL
these	NULL
factors	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
BLR1I	NULL
.	NULL

Like	NULL
Oct-2-deficient	NULL
mice	NULL
,	NULL
Bobl	NULL
knockout	NULL
mice	NULL
(	NULL
30-82	NULL
)	NULL
show	NULL
unaffected	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
but	NULL
have	NULL
severely	NULL
reduced	NULL
numbers	NULL
of	NULL
mature	NULL
B	NULL
cells	NULL
and	NULL
lower	NULL
levels	NULL
of	NULL
secondary	NULL
antibody	NULL
isotypes	NULL
in	NULL
serum	NULL
.	NULL

Most	NULL
important	NULL
is	NULL
the	NULL
observation	NULL
that	NULL
Bobl	NULL
'-	NULL
mice	NULL
completely	NULL
fail	NULL
to	NULL
develop	NULL
germinal	NULL
centers	NULL
following	NULL
immunization	NULL
with	NULL
thymus-dependent	NULL
antigen	NULL
.	NULL

The	NULL
same	NULL
phenotype	NULL
is	NULL
shared	NULL
by	NULL
mice	NULL
with	NULL
the	NULL
targeted	NULL
disruption	NULL
of	NULL
p52/NF-	NULL
«	NULL
B2	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
and	NULL
with	NULL
double	NULL
knockout	NULL
of	NULL
p50/p52	NULL
genes	NULL
(	NULL
85	NULL
)	NULL
.	NULL

Adoptively	NULL
transferred	NULL
p52-deficient	NULL
lymphocytes	NULL
can	NULL
form	NULL
germinal	NULL
centers	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
,	NULL
and	NULL
consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
we	NULL
detected	NULL
unaffected	NULL
expression	NULL
of	NULL
BLR1	NULL
on	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
p50/p52	NULL
double	NULL
knockout	NULL
mice	NULL
development	NULL
of	NULL
B	NULL
cells	NULL
is	NULL
halted	NULL
at	NULL
stage	NULL
B220	NULL
``	NULL
°	NULL
``	NULL
,	NULL
IgM*	NULL
,	NULL
CD23~	NULL
.	NULL

Cells	NULL
with	NULL
this	NULL
phenotype	NULL
are	NULL
also	NULL
found	NULL
in	NULL
normal	NULL
spleens	NULL
,	NULL
although	NULL
at	NULL
low	NULL
frequency	NULL
.	NULL

In	NULL
wild-type	NULL
animals	NULL
,	NULL
these	NULL
cells	NULL
express	NULL
BLR1	NULL
at	NULL
the	NULL
same	NULL
level	NULL
as	NULL
observed	NULL
for	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
``	NULL
but	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
BLR1	NULL
on	NULL
corresponding	NULL
cells	NULL
derived	NULL
from	NULL
double	NULL
knockout	NULL
mice	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
germinal	NULL
centers	NULL
is	NULL
also	NULL
a	NULL
hallmark	NULL
of	NULL
the	NULL
phenotype	NULL
of	NULL
birl-deficient	NULL
mice	NULL
.	NULL

Following	NULL
a	NULL
T	NULL
cell-dependent	NULL
antigenic	NULL
challenge	NULL
,	NULL
B	NULL
cells	NULL
become	NULL
activated	NULL
but	NULL
fail	NULL
to	NULL
migrate	NULL
into	NULL
B	NULL
cell	NULL
follicles	NULL
of	NULL
the	NULL
spleen	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
germinal	NULL
centers	NULL
do	NULL
not	NULL
develop	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
severely	NULL
reduced	NULL
expression	NULL
of	NULL
BLR1	NULL
in	NULL
both	NULL
Bobl	NULL
and	NULL
p50/p52	NULL
null	NULL
mice	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
germinal	NULL
center	NULL
reactions	NULL
in	NULL
these	NULL
animals	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
impaired	NULL
B	NULL
lymphocyte	NULL
migration	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
grateful	NULL
to	NULL
Thomas	NULL
Wirth	NULL
for	NULL
providing	NULL
the	NULL
Abl/Oct2-ER	NULL
cell	NULL
line	NULL
,	NULL
Lynn	NULL
Corcoran	NULL
for	NULL
providing	NULL
Oct-2*~	NULL
mice	NULL
,	NULL
Peter	NULL
J.	NULL
Nielsen	NULL
for	NULL
Bob1	NULL
'~	NULL
mice	NULL
,	NULL
and	NULL
Anita	NULL
Mattis	NULL
for	NULL
the	NULL
1299V	NULL
bir1	NULL
genomic	NULL
library	NULL
clone	NULL
.	NULL

We	NULL
thank	NULL
Melanie	NULL
Fischer	NULL
,	NULL
Dagmar	NULL
Breitfeld	NULL
,	NULL
and	NULL
Oliver	NULL
Miick	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Gunn	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Ngo	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
Ansel	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Ekland	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Cyster	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
and	NULL
Williams	NULL
,	NULL
L.	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Nature	NULL
391	NULL
,	NULL
799-803	NULL
2	NULL
.	NULL

Legler	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Loctscher	NULL
,	NULL
M.	NULL
,	NULL
Stuber	NULL
Roos	NULL
,	NULL
R.	NULL
,	NULL
Clark-Lewis	NULL
,	NULL
L.	NULL
,	NULL
Baggiolini	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Moser	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187	NULL
,	NULL
655-660	NULL
3	NULL
.	NULL

Dobner	NULL
,	NULL
T.	NULL
,	NULL
Wolf	NULL
,	NULL
L.	NULL
,	NULL
Emrich	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Lipp	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22	NULL
,	NULL
2795-2799	NULL
4	NULL
.	NULL

Kaiser	NULL
,	NULL
E.	NULL
,	NULL
Forster	NULL
,	NULL
R.	NULL
,	NULL
Wolf	NULL
,	NULL
I.	NULL
,	NULL
Ebensperger	NULL
,	NULL
C.	NULL
,	NULL
Kuehl	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
and	NULL
Lipp	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
2532-2589	NULL
5	NULL
.	NULL

Kouba	NULL
,	NULL
M.	NULL
,	NULL
Vanetti	NULL
,	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
X.	NULL
,	NULL
Schafer	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hollt	NULL
,	NULL
V.	NULL
(	NULL
1998	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

821	NULL
,	NULL
173-178	NULL
.	NULL

Forster	NULL
,	NULL
R.	NULL
,	NULL
Emrich	NULL
,	NULL
T.	NULL
,	NULL
Kremmer	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Lipp	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
880-840	NULL
.	NULL

Forster	NULL
,	NULL
R.	NULL
,	NULL
Mattis	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Kremmer	NULL
,	NULL
E.	NULL
,	NULL
Wolf	NULL
,	NULL
E.	NULL
,	NULL
Brem	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Lipp	NULL
,	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
1087-1047	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
13-20	NULL
.	NULL

Verrijzer	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
and	NULL
Van	NULL
der	NULL
Vliet	NULL
,	NULL
P.	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1178	NULL
,	NULL
1-21	NULL
10	NULL
.	NULL

Herr	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Cleary	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
1679-1698	NULL
11	NULL
.	NULL

Gstaiger	NULL
,	NULL
M.	NULL
,	NULL
Knoepfel	NULL
,	NULL
L.	NULL
,	NULL
Georgiev	NULL
,	NULL
O.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Hovens	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
878	NULL
,	NULL
360-362	NULL
12	NULL
.	NULL

Strubin	NULL
,	NULL
M.	NULL
,	NULL
Newell	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
497-506	NULL
13	NULL
.	NULL

Luo	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
4115-4124	NULL
14	NULL
.	NULL

Pfisterer	NULL
,	NULL
P.	NULL
,	NULL
Zwilling	NULL
,	NULL
S.	NULL
,	NULL
Hess	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
29870-29880	NULL
15	NULL
.	NULL

Schubart	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Sauter	NULL
,	NULL
P.	NULL
,	NULL
Massa	NULL
,	NULL
S.	NULL
,	NULL
Friedl	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Schwarzenbach	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

24	NULL
,	NULL
1913-1920	NULL
16	NULL
.	NULL

Gstaiger	NULL
,	NULL
M.	NULL
,	NULL
Georgiev	NULL
,	NULL
O.	NULL
,	NULL
van	NULL
Leeuwen	NULL
,	NULL
H.	NULL
,	NULL
van	NULL
der	NULL
Vliet	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
2781-2790	NULL
17	NULL
.	NULL

Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Karvelas	NULL
,	NULL
M.	NULL
,	NULL
Nossal	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Ye	NULL
,	NULL
Z.	NULL
S.	NULL
,	NULL
Jacks	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
570-582	NULL
18	NULL
.	NULL

Konig	NULL
,	NULL
H.	NULL
,	NULL
Pfisterer	NULL
,	NULL
P.	NULL
,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
1598-1607	NULL
~	NULL
t	NULL
co	NULL
*	NULL
R.	NULL
Forster	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
28836	NULL
19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

Pfisterer	NULL
,	NULL
P.	NULL
,	NULL
Kénig	NULL
,	NULL
H.	NULL
,	NULL
Hess	NULL
,	NULL
J.	NULL
,	NULL
Lipowsky	NULL
,	NULL
G.	NULL
,	NULL
Haendler	NULL
,	NULL
B.	NULL
,	NULL
Schleuning	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
6160-6168	NULL
Hartl	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Lipp	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
2037-2045	NULL
Frebourg	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Brison	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

65	NULL
,	NULL
315-818	NULL
Miiller-Immergliick	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
1625-1684	NULL
Thalmeier	NULL
,	NULL
K.	NULL
,	NULL
Synovzik	NULL
,	NULL
H.	NULL
,	NULL
Mertz	NULL
,	NULL
R.	NULL
,	NULL
Winnacker	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
and	NULL
Lipp	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
527-586	NULL
Smale	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
103-113	NULL
Pfisterer	NULL
,	NULL
P.	NULL
,	NULL
Annweiler	NULL
,	NULL
A.	NULL
,	NULL
Ullmer	NULL
,	NULL
C.	NULL
,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
1655-1663	NULL
Shah	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Bertolino	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Singh	NULL
,	NULL
H.	NULL
(	NULL
1997	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

16	NULL
,	NULL
7105-7117	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Zorbas	NULL
,	NULL
H.	NULL
,	NULL
Winnacker	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
6497-6502	NULL
Arnosti	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
Merino	NULL
,	NULL
A.	NULL
,	NULL
Reinberg	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
157-166	NULL
29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

Oct-2-dependent	NULL
Expression	NULL
of	NULL
BLR1	NULL
Zwilling	NULL
,	NULL
S.	NULL
,	NULL
Annweiler	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
1655-1662	NULL
Kim	NULL
,	NULL
U.	NULL
,	NULL
Qin	NULL
,	NULL
X.	NULL
F.	NULL
,	NULL
Gong	NULL
,	NULL
S.	NULL
,	NULL
Stevens	NULL
,	NULL
S.	NULL
,	NULL
Luo	NULL
,	NULL
Y.	NULL
,	NULL
Nussenzweig	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
888	NULL
,	NULL
542-547	NULL
Schubart	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Rolink	NULL
,	NULL
A.	NULL
,	NULL
Kosco-Vilbois	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Botteri	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
888	NULL
,	NULL
588-542	NULL
Nielsen	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Georgiev	NULL
,	NULL
O.	NULL
,	NULL
Lorenz	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1996	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26	NULL
,	NULL
3214-8218	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
Carlson	NULL
,	NULL
L.	NULL
,	NULL
Poljak	NULL
,	NULL
L.	NULL
,	NULL
Shores	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
Epstein	NULL
,	NULL
S.	NULL
,	NULL
Leonardi	NULL
,	NULL
A.	NULL
,	NULL
Grinberg	NULL
,	NULL
A.	NULL
,	NULL
Tran	NULL
,	NULL
T.	NULL
,	NULL
Scharton-Kersten	NULL
,	NULL
T.	NULL
,	NULL
Anver	NULL
,	NULL
M.	NULL
,	NULL
Love	NULL
,	NULL
P.	NULL
,	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187	NULL
,	NULL
147-159	NULL
Caamano	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Rizzo	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Durham	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Barton	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Raventos-Suarez	NULL
,	NULL
C.	NULL
,	NULL
Snapper	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187	NULL
,	NULL
185-196	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
Carlson	NULL
,	NULL
L.	NULL
,	NULL
Xing	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
Poljak	NULL
,	NULL
L.	NULL
,	NULL
Shores	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
Brown	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Leonardi	NULL
,	NULL
A.	NULL
,	NULL
Tran	NULL
,	NULL
T.	NULL
,	NULL
Boyce	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

11	NULL
,	NULL
3482-3496	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Downstream	NULL
Activation	NULL
of	NULL
a	NULL
TATA-less	NULL
Promoter	NULL
by	NULL
Oct-2	NULL
,	NULL
Bob1	NULL
,	NULL
and	NULL
NF-KB	NULL
Directs	NULL
Expression	NULL
of	NULL
the	NULL
Homing	NULL
Receptor	NULL
BLR1	NULL
to	NULL
Mature	NULL
B	NULL
Cells	NULL
Ingrid	NULL
Wolf	NULL
,	NULL
Veniamin	NULL
Pevzner	NULL
,	NULL
Edelgard	NULL
Kaiser	NULL
,	NULL
Giinter	NULL
Bernhardt	NULL
,	NULL
Estefania	NULL
Claudio	NULL
,	NULL
Ulrich	NULL
Siebenlist	NULL
,	NULL
Reinhold	NULL
Forster	NULL
and	NULL
Martin	NULL
Lipp	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1998	NULL
,	NULL
273:28831-28836.	NULL
doi	NULL
:	NULL
10.1074/jb0.273.44.28831	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/273/44/28831	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
35	NULL
references	NULL
,	NULL
14	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

